Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.

Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR.

Blood. 2009 Dec 3;114(24):5062-70. doi: 10.1182/blood-2009-06-227587. Epub 2009 Oct 14.

2.

Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.

Brandacher G, Margreiter R, Fuchs D.

Curr Drug Metab. 2007 Apr;8(3):273-82. Review.

PMID:
17430115
3.

Indoleamine 2,3-dioxygenase in transplantation.

Mulley WR, Nikolic-Paterson DJ.

Nephrology (Carlton). 2008 Jun;13(3):204-11. doi: 10.1111/j.1440-1797.2007.00921.x. Epub 2008 Jan 23. Review.

PMID:
18221253
4.

Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

Zamanakou M, Germenis AE, Karanikas V.

Immunol Lett. 2007 Aug 15;111(2):69-75. Epub 2007 Jul 2. Review.

PMID:
17644189
5.

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

Katz JB, Muller AJ, Prendergast GC.

Immunol Rev. 2008 Apr;222:206-21. doi: 10.1111/j.1600-065X.2008.00610.x. Review.

PMID:
18364004
6.

IDO: a double-edged sword for T(H)1/T(H)2 regulation.

Xu H, Zhang GX, Ciric B, Rostami A.

Immunol Lett. 2008 Nov 16;121(1):1-6. doi: 10.1016/j.imlet.2008.08.008. Epub 2008 Sep 29. Review.

7.

Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.

Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P.

Curr Drug Metab. 2007 Apr;8(3):209-16. Review.

PMID:
17430109
8.

Molecules in focus: indoleamine 2,3-dioxygenase.

King NJ, Thomas SR.

Int J Biochem Cell Biol. 2007;39(12):2167-72. Epub 2007 Jan 20. Review.

PMID:
17320464
9.

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH.

Int J Biochem Cell Biol. 2009 Mar;41(3):467-71. doi: 10.1016/j.biocel.2008.01.005. Epub 2008 Jan 11. Review.

PMID:
18282734
10.

The end of the road for the tryptophan depletion concept in pregnancy and infection.

Badawy AA, Namboodiri AM, Moffett JR.

Clin Sci (Lond). 2016 Aug 1;130(15):1327-33. doi: 10.1042/CS20160153. Review.

11.

IDO expression in the brain: a double-edged sword.

Kwidzinski E, Bechmann I.

J Mol Med (Berl). 2007 Dec;85(12):1351-9. Epub 2007 Jun 27. Review.

PMID:
17594069
12.

Indoleamine-2,3-dioxygenase modulation of allergic immune responses.

Le AV, Broide DH.

Curr Allergy Asthma Rep. 2006 Feb;6(1):27-31. Review.

PMID:
16476191
13.

Tryptophan catabolism and T cell responses.

Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, Jhaver K, Baban B.

Adv Exp Med Biol. 2003;527:27-35. Review.

PMID:
15206713
14.

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy.

Brochez L, Chevolet I, Kruse V.

Eur J Cancer. 2017 May;76:167-182. doi: 10.1016/j.ejca.2017.01.011. Epub 2017 Mar 18. Review.

PMID:
28324751
15.

Indoleamine 2,3-dioxygenase: is it an immune suppressor?

Soliman H, Mediavilla-Varela M, Antonia S.

Cancer J. 2010 Jul-Aug;16(4):354-9. doi: 10.1097/PPO.0b013e3181eb3343. Review.

16.

The kynurenine system and immunoregulation.

Mándi Y, Vécsei L.

J Neural Transm (Vienna). 2012 Feb;119(2):197-209. doi: 10.1007/s00702-011-0681-y. Epub 2011 Jul 9. Review.

PMID:
21744051
17.

Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host.

Zelante T, Fallarino F, Bistoni F, Puccetti P, Romani L.

Microbes Infect. 2009 Jan;11(1):133-41. doi: 10.1016/j.micinf.2008.10.007. Epub 2008 Oct 25. Review.

PMID:
19007906
18.

Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer.

Prendergast GC, Smith C, Thomas S, Mandik-Nayak L, Laury-Kleintop L, Metz R, Muller AJ.

Cancer Immunol Immunother. 2014 Jul;63(7):721-35. doi: 10.1007/s00262-014-1549-4. Epub 2014 Apr 8. Review.

19.

Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.

Strasser B, Becker K, Fuchs D, Gostner JM.

Neuropharmacology. 2017 Jan;112(Pt B):286-296. doi: 10.1016/j.neuropharm.2016.02.030. Epub 2016 Feb 26. Review.

PMID:
26924709
20.

HDAC inhibition and graft versus host disease.

Choi S, Reddy P.

Mol Med. 2011 May-Jun;17(5-6):404-16. doi: 10.2119/molmed.2011.00007. Epub 2011 Jan 8. Review.

Supplemental Content

Support Center